Skip to main content
. 2014 Jul 18;307(6):H840–H847. doi: 10.1152/ajpheart.00312.2014

Fig. 3.

Fig. 3.

Effect of inflammation on MRT and change with acute ascorbic acid infusion. A: C-reactive protein (CRP) <3 mg/l (n = 25), CRP >3 mg/l (n = 6). Consistent with clinical guidelines, those subjects with CRP levels >3 mg/l tended to exhibit longer baseline MRT (P = 0.09). B: those subjects with CRP levels >3 mg/l tended to exhibit a greater reduction in MRT (Δ) with ascorbic acid infusion (P = 0.07) compared with adults with CRP levels <3 mg/l. †P < 0.10 vs. CRP <3 mg/l.